Person: YILDIZ, PELİN
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Organizational Unit
Job Title
Last Name
YILDIZ
First Name
PELİN
Name
17 results
Search Results
Now showing 1 - 10 of 17
- PublicationMetadata onlyA Case of Multiple Familial Trichoepitelioma with Malignant Transformation Successfully Treated with Vismodegib.(2020-05-13T00:00:00Z) Cengiz, Fatma Pelin; Kelahmetoglu, Osman; Yildiz, P; Tekce, E; Akarslan, Tc; Shbair, A; Seker, M; Onsun, N; KELAHMETOĞLU, OSMAN; YILDIZ, PELİN; YENİGÜN, ALPER; TEKÇE, ERTUĞRUL
- PublicationMetadata onlyThe Effects of Micronized Progesterone and Cabergoline On a Rat Autotransplantation Endometriosis Model: A Placebo Controlled Randomized Trial.(2020-01-06T00:00:00Z) Karslıoglu, T; Karasu, AFG; Yildiz, PELİN; YILDIZ, PELİN
- PublicationMetadata onlyHistopathological Features of Paratesticular Solid Tumors: 5 Years Experience(2020-05-01T00:00:00Z) Çoban, Ganime; Yıldız, Pelin; Kıran, Tuğçe; Ersöz, Cevper; ÇOBAN, GANİME; YILDIZ, PELİN; KIRAN, TUĞÇE; ERSÖZ, CEVPER
- PublicationMetadata onlyThe role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes(2020-09-01T00:00:00Z) Serter, Asli; ONUR, MEHMET RUHİ; ÇOBAN, Ganime; YILDIZ, PELİN; Armagan, Abdullah; Kocakoc, Ercan; ÇOBAN, GANİME; YILDIZ, PELİNPurpose To assess the value of diffusion-weighted magnetic resonance imaging (DW-MRI) and contrast-enhanced MRI (CE-MRI) for differentiation between benign and malignant solid renal masses, renal cell carcinoma (RCC) subtypes, oncocytomas, and lipid-poor angiomyolipomas (LP-AML). Methods Minimum or lowest -apparent diffusion coefficient- (ADC(1)) and representative ADC values (ADC(2)) of 112 renal masses (n: 46 benign renal mass,n: 66 malignant renal mass) were measured on DW-MRI images (b50, 400, 800 s/mm(2)). Signal intensity (SI) measurements were performed in normal renal parenchyma and most avid enhanced area of the renal masses at precontrast, corticomedullary, and nephrographic phases on CE-MRI. Contrast enhancement rate (CER) and contrast enhancement index (CEI) values of renal masses were compared between benign-malignant renal masses and RCC subtypes, oncocytomas, and LP-AMLs. Results There was no significant difference between ADC(1), ADC(2)values, and SI of benign and malignant renal masses (p = 0.721,p = 0.255,p = 0.872). Mean ADC(1)and ADC(2)values of clear cell RCCs were significantly higher than nonclear cell RCCs (p = 0.005p = 0.002). Mean CER value of clear cell RCCs was significantly higher than nonclear cell RCCs in nephrographic phase (p = 0.003). Mean CEI values of clear cell RCCs were significantly higher than nonclear cell RCCs in the corticomedullary and nephrographic phase (p = 0.027 vs. 0.008). LP-AMLs were differentiated from other renal masses with wash-out phenomenon. Conclusion Combined usage of ADC, SI, CER, and CEI values may be useful for discrimination between RCC subtypes, oncocytomas, and lipid-poor AMLs.
- PublicationMetadata onlyMalignant melanoma of breast arising in a burn scar.(2021-01-23T00:00:00Z) Durgun, Ufuk; Camli, Mehmet Fatih; Yıldız, PELİN; Yildiz, Kemalettin; YILDIZ, PELİN
- PublicationOpen AccessClinical and histopathological improvement of scleromyxedema-induced microstomia after hyaluronidase injection(2022-05-01T00:00:00Z) AKASLAN, TAHSİN ÇAĞDAŞ; YILDIZ, PELİN; ONSUN, Nahide; AKASLAN, TAHSİN ÇAĞDAŞ; YILDIZ, PELİN; ONSUN, NAHIDEIntroduction Scleromyxedema is a rare primary cutaneous mucinosis characterized by numerous firm, waxy, confluent papules. Recently, intravenous immunoglobulin (IVIG) is accepted by many authors as the first-line treatment option for severe cases. We report a 69-year-old male patient who has been suffering from scleromyxedema, with reduced mouth opening. He has been on a high-dose IVIG regime for 5 years. Methods The patient stated that he had difficulty in wearing and removing his dentures because of reduced mouth opening lately. Before considering to add any other immunosuppressants to his regime, we injected 1500 IU of hyaluronidase in total in one session periorally. The patient has been told open his mouth maximum and photographs have been taken before injections and after one month. We used a photo measurement application when evaluating microstomia to increase accuracy. We also took punch biopsies in order to evaluate effect of hyaluronidase histopathologically before and one month after injections. Results One month later, he was able to reattach and remove his dentures without adding any adjuvant immunosuppressants other than hyaluronidase. Mouth opening was increased in measurements and histopathologically, mucin deposition, fibroblastic proliferation, and perivascular lymphocytic infiltration were decreased. Conclusions We think hyaluronidase is a safe, easily accessible, and effective treatment option for microstomia caused by scleromyxedema.
- PublicationMetadata onlyBenign prostat hiperplazisinin cerrahi tedavisi sonrası tanı konulan insidental prostat kanseri(2021-10-01T00:00:00Z) İlktaç, Abdullah; Ersöz, Cevper; Doğan, Bayram; Akçay, Muzaffer; Yıldız, Pelin; Çoban, Ganime; Akbulut, Habib; İLKTAÇ, ABDULLAH; ERSÖZ, CEVPER; DOĞAN, BAYRAM; AKÇAY, MUZAFFER; YILDIZ, PELİN; ÇOBAN, GANİME; AKBULUT, HABİB
- PublicationMetadata onlySurgical treatment of adult-onset xanthogranuloma(2020-05-29T04:00:00Z) Sonmez Ergun, Selma; KİRAZOĞLU, AHMET; YILDIZ, PELİN; ERGÜN, SELMA; KİRAZOĞLU, AHMET; YILDIZ, PELİN
- PublicationMetadata onlyProliferating Pilar Tumors: Could Immunohistochemistry be Helpful to Differ Benign and Malignant Forms?(2020-03-01T00:00:00Z) YILDIZ, PELİN; AYDIN ÜLGEN, Övgü; Yol, Cansu; DEMİRKESEN, Cüyan; YILDIZ, PELİN
- PublicationMetadata onlyCurrent Approach to the Prognostic Parameters of Testicular Germ Cell tumors Accompanied by Our Cases(2020-08-01T00:00:00Z) Çoban, Ganime; Yıldız, Pelin; Sezal, Zeynep; Adıllı, Adile; Beşiroğlu, Mehmet; Akçay, Muzaffer; Gücin, Zühal; ÇOBAN, GANİME; YILDIZ, PELİN; BEŞİROĞLU, MEHMET; AKÇAY, MUZAFFER; GÜCİN, ZÜHAL